Quick Takeaways
- Iroquois Capital Management, LLC filed SCHEDULE 13G for Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO).
- Disclosed ownership: 5.4%.
- Date of event: 16 Sep 2025.
Iroquois Capital Management, LLC - 16 Sep 2025 SCHEDULE 13G Report for Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO)
- Filing Manager
- Iroquois Capital Management, LLC
- Reporting Manager
- Richard Abbe
- Symbol
- BNGO
- Shares outstanding
- 9,722,222 shares
- Disclosed Ownership
- 525,000 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Sep 2025, 08:13:20 UTC
- Date of event
- 16 Sep 2025
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Iroquois Capital Management, LLC disclosed 5.4% ownership in Bionano Genomics, Inc. Common Stock, par value $0.0001 per share (BNGO) on 16 Sep 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Sep 2025, 08:13.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Iroquois Capital Management, LLC | 3.8% | 367,500 | 0 | 367,500 | /s/ Richard Abbe | Richard Abbe, President | |
| Richard Abbe | 5.4% | 525,000 | 157,500 | 367,500 | /s/ Richard Abbe | Richard Abbe | |
| Kimberly Page | 3.8% | 367,500 | 0 | 367,500 | /s/ Kimberly Page | Kimberly Page |